Literature DB >> 7462803

Hydroxylation of cholic, chenodeoxycholic, and deoxycholic acids in patients with intrahepatic cholestasis.

A Bremmelgaard, J Sjövall.   

Abstract

The metabolism of 14C-labeled chenodeoxycholic, cholic, and deoxycholic acids was studied in patients with intrahepatic cholestasis. Radioactively labeled metabolites were isolated from urine and were identified by gas-liquid chromatography-mass spectrometry. About 5% of the radioactivity was recovered in urine after administration of labeled chenodeoxycholic acid to a patient with mild intrahepatic cholestasis. In urine collected 0-24 hr after the injection, 20% of the radioactivity appeared in the combined glycine and taurine conjugate fractions, and the predominant metabolite in these fractions was identified as hyocholic acid. Eighty percent of the activity was eluted in the sulfate fraction presumably representing mainly sulfated chenodeoxycholic acid conjugates. Twenty percent of the radioactivity was recovered in urine following administration of labeled cholic acid to a patient with biliary cirrhosis and severe cholestasis. In urine collected on the fifth day, half of this radioactivity appeared in the glycine and taurine conjugate fractions, and 10% of this activity was present as tetrahydroxycholanoates. The major metabolites in this fraction were 3 alpha, 6 alpha, 7 alpha, 12 alpha-tetrahydroxy-5 beta- and 1 xi, 3 alpha, 7 alpha, 12 alpha-tetrahydroxy-5 beta-cholanoic acids. The former compound constituted about 50% of the tetrahydroxycholanoates. Three additional minor tetrahydroxy bile acids were present, one of which was tentatively identified as 6 beta-hydroxycholic acid. About 5% of the radioactivity appeared in urine after oral administration of labeled deoxycholic acid to a patient with mild intrahepatic cholestasis. Twenty-two percent of the activity appeared in the glycine and taurine conjugate fractions isolated from urine collected on the second day after the administration. About 75% of this activity was associated with trihydroxycholanoates. The main metabolite was 1 beta-hydroxydeoxycholic acid with small amounts of, tentatively, 6 alpha-hydroxydeoxycholic acid.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7462803

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  14 in total

1.  Hepatobiliary disposition of 3alpha,6alpha,7alpha,12alpha-tetrahydroxy-cholanoyl taurine: a substrate for multiple canalicular transporters.

Authors:  Vandana Megaraj; Takashi Iida; Paiboon Jungsuwadee; Alan F Hofmann; Mary Vore
Journal:  Drug Metab Dispos       Date:  2010-07-19       Impact factor: 3.922

2.  Glucuronidation of 6 alpha-hydroxy bile acids by human liver microsomes.

Authors:  A Radomińska-Pyrek; P Zimniak; Y M Irshaid; R Lester; T R Tephly; J St Pyrek
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

3.  Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep (-/-) mice.

Authors:  Eugene Hrycay; Dana Forrest; Lin Liu; Renxue Wang; Jenny Tai; Anand Deo; Victor Ling; Stelvio Bandiera
Journal:  Mol Cell Biochem       Date:  2014-01-08       Impact factor: 3.396

4.  Fifty years with bile acids and steroids in health and disease.

Authors:  Jan Sjövall
Journal:  Lipids       Date:  2004-08       Impact factor: 1.880

Review 5.  Chemical and metabolic transformations of selected bile acids.

Authors:  K Kuhajda; S Kevresan; J Kandrac; J P Fawcett; M Mikov
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2006 Jul-Sep       Impact factor: 2.441

6.  Bile acid N-acetylglucosaminidation. In vivo and in vitro evidence for a selective conjugation reaction of 7 beta-hydroxylated bile acids in humans.

Authors:  H U Marschall; H Matern; H Wietholtz; B Egestad; S Matern; J Sjövall
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

7.  Postnatal physiologic hypercholemia in both premature and full-term infants.

Authors:  S Barnes; G Berkowitz; B I Hirschowitz; D Wirtschafter; G Cassady
Journal:  J Clin Invest       Date:  1981-09       Impact factor: 14.808

Review 8.  Nuclear receptors as therapeutic targets in cholestatic liver diseases.

Authors:  Gernot Zollner; Michael Trauner
Journal:  Br J Pharmacol       Date:  2009-01       Impact factor: 8.739

9.  Phenobarbital-induced alterations of bile acid metabolism in cases of intrahepatic cholestasis.

Authors:  P Back
Journal:  Klin Wochenschr       Date:  1982-06-01

10.  Plasma bile acid concentrations in patients with human immunodeficiency virus infection receiving protease inhibitor therapy: possible implications for hepatotoxicity.

Authors:  MaryPeace McRae; Naser L Rezk; Arlene S Bridges; Amanda H Corbett; Hsiao-Chuan Tien; Kim L R Brouwer; Angela D M Kashuba
Journal:  Pharmacotherapy       Date:  2010-01       Impact factor: 4.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.